Trademark Overview
On Wednesday, December 27, 2023, a trademark application was filed for RENBIOLOGICS with the United States Patent and Trademark Office. The USPTO has given the RENBIOLOGICS trademark a serial number of 79395221. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, August 9, 2024. This trademark is owned by Biocytogen Pharmaceuticals (Beijing) Co., Ltd.. The RENBIOLOGICS trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Medicines for human purposes; biological preparations for medical purposes; preparations of microorganisms for medical or veterinary use; biological tissue cultures for medical purposes; colostral antibodies for medical purposes; vaccines; living cells for medical purposes; biochemical medicines; pharmaceutical preparations; pharmaceutical substances; medical preparations for treating diseases and disorders related to the immune system; pharmaceutical preparations for the prevention and treatment of cancer; diagnostic preparations for medical purposes; dietetic substances adapted for medical use; medicines for veterinary purposes.
Protein [raw material]; radioactive elements for scientific purposes; preparations of trace elements for plants; biochemical preparations for scientific purposes; biological preparations, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; biological tissue cultures other than for medical or veterinary purpose; bacteriological preparations other than for medical and veterinary use; preparations of microorganisms, other than for medical and veterinary use; proteins for the food industry.
Technological research; biochemical research and analysis; drug development; pharmaceutical product evaluation; clinical trials; research and development services in the field of antibodies; biological research; research in the field of gene editing technology; research in the field of cell engineering technology; culturing of cells for scientific research purposes; development of pharmaceutical preparations and pharmaceuticals; biomedical research.
